NEW YORK, Jan. 18, 2017 /PRNewswire/ --

Abeona Therapeutics Inc. (ABEO)

Lifshitz & Miller announces investigation on behalf of ABEO investors concerning whether ABEO adequately disclosed information regarding ABEO's proposed gene therapy treatment for Sanfilippo syndrome.

If you are an ABEO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Agile Therapeutics, Inc. (AGRX)

Lifshitz & Miller announces investigation on behalf of AGRX investors concerning whether AGRX adequately disclosed information concerning the effectiveness of AGRX's contraceptive, Twirla.

If you are an AGRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Alere Inc. (ALR)

Lifshitz & Miller announces investigation on behalf of ALR investors concerning whether ALR's wholly-owned subsidiary, Arriva Medical, LLC, was submitting claims to Medicare for deceased patients.

If you are an ALR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Floteck Industries, Inc. (FTK)

Lifshitz & Miller announces investigation on behalf of FTK investors concerning whether FTK adequately disclosed information regarding the data used in FTK's studies in the oil production process.

If you are an FTK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Insys Therapeutics Inc. (INSY)

Lifshitz & Miller announces investigation on behalf of INSY investors concerning whether INSY was distributing illegal kickbacks to healthcare providers and engaged in the off-label promotion of its medical devices.

If you are an INSY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

MTS Systems Corporation (MTSC)

Lifshitz & Miller announces investigation on behalf of MTSC investors concerning whether MTSC adequately disclosed information regarding MTSC's business as a result of purported violations of MTSC's code of conduct in China.

If you are an MTSC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Ophthotech Corporation (OPHT)

Lifshitz & Miller announces investigation on behalf of OPHT investors concerning whether OPHT adequately disclosed information concerning OPHT's phase 3 clinical trials of Fovista.

If you are an OPHT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Teekay Corporation (TK)

Lifshitz & Miller announces investigation on behalf of TK investors concerning whether TK adequately disclosed information concerning its quarterly dividend of $0.55 per share.

If you are a TK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780
 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-abeona-therapeutics-inc-agile-therapeutics-inc-alere-inc-floteck-industries-inc-insys-therapeutics-inc-mts-systems-corporation-ophthotech-corporation-and-teekay-co-300392818.html

SOURCE Lifshitz & Miller Law Firm